In this video, Jeremie Calais, MD, PhD, describes the rationale for the report, “Standardized template for clinical reporting of PSMA PET/CT scans.” Calais is a nuclear medicine physician at the ...

"The final rule for 2025 poses several challenges to urology. Lobbying efforts to preserve telehealth access and the CF will continue, perhaps dragging into 2025," write Jonathan Rubenstein, MD, and ...

BCG-unresponsive NMIBC is defined by persistent or recurrent high-grade tumors or carcinoma in situ after adequate BCG therapy. This condition requires alternative therapeutic strategies or radical ...

OAB exhibits distinct pathophysiological differences in men and women, complicating diagnosis due to symptom overlap with BPH in men. Engaging patients in the diagnostic process is crucial for ...

Experts discuss overactive bladder and the impacts on quality of life, distinguishing OAB from BPH, and how a delayed diagnosis can worsen symptoms.

Panelists discuss how metastatic castration-sensitive prostate cancer (mCSPC) is managed with a combination of androgen deprivation therapy, chemotherapy, and novel agents like such as abiraterone and ...

Panelists discuss how metastatic castration-sensitive prostate cancer (mCSPC) is managed with a combination of androgen deprivation therapy, chemotherapy, and novel agents like such as abiraterone and ...

"Honestly, there really isn't another measure of sexual quality of life for females that addresses the specific concerns of the female partners of patients with prostate cancer," says Stacy Loeb, MD, ...

"I'm hopeful that the decisions are more informed in terms of actual science," says Daniel Kwon, MD. In this video, Daniel Kwon, MD, discusses the impact of the JNCI Cancer Spectrum paper, “Germline ...

FK-PC101 is a personalized immunotherapy using irradiated autologous tumor cells to prevent prostate cancer recurrence post-prostatectomy. The CELLVX-230 trial, enrolling 100 high-risk patients, is ...

In this video, Jason M. Hafron, MD, explains how PSMA-PET has enabled the use of more targeted treatment approaches in the management of oligometastatic prostate cancer. Hafron is the chief medical ...

AI scribe technology at Emory University aids in efficient clinical note-taking, potentially enhancing physician satisfaction and reducing after-hours electronic health record usage. AI algorithms are ...